These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 11428925)

  • 1. Heterocycle-containing retinoids. Discovery of a novel isoxazole arotinoid possessing potent apoptotic activity in multidrug and drug-induced apoptosis-resistant cells.
    Simoni D; Roberti M; Invidiata FP; Rondanin R; Baruchello R; Malagutti C; Mazzali A; Rossi M; Grimaudo S; Capone F; Dusonchet L; Meli M; Raimondi MV; Landino M; D'Alessandro N; Tolomeo M; Arindam D; Lu S; Benbrook DM
    J Med Chem; 2001 Jul; 44(14):2308-18. PubMed ID: 11428925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Programmed cell death (PCD) associated with the stilbene motif of arotinoids: discovery of novel apoptosis inducer agents possessing activity on multidrug resistant tumor cells.
    Simoni D; Roberti M; Invidiata FP; Rondanin R; Baruchello R; Malagutti C; Mazzali A; Rossi M; Grimaudo S; Dusonchet L; Meli M; Raimondi MV; D'Alessandro N; Tolomeo M
    Bioorg Med Chem Lett; 2000 Dec; 10(23):2669-73. PubMed ID: 11128648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationship studies of novel heteroretinoids: induction of apoptosis in the HL-60 cell line by a novel isoxazole-containing heteroretinoid.
    Simoni D; Invidiata FP; Rondanin R; Grimaudo S; Cannizzo G; Barbusca E; Porretto F; D'Alessandro N; Tolomeo M
    J Med Chem; 1999 Dec; 42(24):4961-9. PubMed ID: 10585206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterocyclic and phenyl double-bond-locked combretastatin analogues possessing potent apoptosis-inducing activity in HL60 and in MDR cell lines.
    Simoni D; Grisolia G; Giannini G; Roberti M; Rondanin R; Piccagli L; Baruchello R; Rossi M; Romagnoli R; Invidiata FP; Grimaudo S; Jung MK; Hamel E; Gebbia N; Crosta L; Abbadessa V; Di Cristina A; Dusonchet L; Meli M; Tolomeo M
    J Med Chem; 2005 Feb; 48(3):723-36. PubMed ID: 15689156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential regulation of human ectocervical epithelial cell line proliferation and differentiation by retinoid X receptor- and retinoic acid receptor-specific retinoids.
    Agarwal C; Chandraratna RA; Teng M; Nagpal S; Rorke EA; Eckert RL
    Cell Growth Differ; 1996 Apr; 7(4):521-30. PubMed ID: 9052993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptosis induction in cancer cells by a novel analogue of 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalenecarboxylic acid lacking retinoid receptor transcriptional activation activity.
    Dawson MI; Hobbs PD; Peterson VJ; Leid M; Lange CW; Feng KC; Chen Gq ; Gu J; Li H; Kolluri SK; Zhang Xk ; Zhang Y; Fontana JA
    Cancer Res; 2001 Jun; 61(12):4723-30. PubMed ID: 11406543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of retinoid X receptors induces apoptosis in HL-60 cell lines.
    Nagy L; Thomázy VA; Shipley GL; Fésüs L; Lamph W; Heyman RA; Chandraratna RA; Davies PJ
    Mol Cell Biol; 1995 Jul; 15(7):3540-51. PubMed ID: 7791761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel atypical retinoid endowed with proapoptotic and antitumor activity.
    Cincinelli R; Dallavalle S; Merlini L; Penco S; Pisano C; Carminati P; Giannini G; Vesci L; Gaetano C; Illy B; Zuco V; Supino R; Zunino F
    J Med Chem; 2003 Mar; 46(6):909-12. PubMed ID: 12620066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of synthetic nuclear retinoid receptor-selective retinoids on the growth of human non-small cell lung carcinoma cells.
    Sun SY; Yue P; Dawson MI; Shroot B; Michel S; Lamph WW; Heyman RA; Teng M; Chandraratna RA; Shudo K; Hong WK; Lotan R
    Cancer Res; 1997 Nov; 57(21):4931-9. PubMed ID: 9354460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinoids, apoptosis and cancer.
    Simoni D; Tolomeo M
    Curr Pharm Des; 2001 Nov; 7(17):1823-37. PubMed ID: 11562311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heteroarotinoids inhibit head and neck cancer cell lines in vitro and in vivo through both RAR and RXR retinoic acid receptors.
    Zacheis D; Dhar A; Lu S; Madler MM; Klucik J; Brown CW; Liu S; Clement F; Subramanian S; Weerasekare GM; Berlin KD; Gold MA; Houck JR; Fountain KR; Benbrook DM
    J Med Chem; 1999 Oct; 42(21):4434-45. PubMed ID: 10543887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of activation-induced apoptosis of thymocytes by all-trans- and 9-cis-retinoic acid is mediated via retinoic acid receptor alpha.
    Szondy Z; Reichert U; Bernardon JM; Michel S; Tóth R; Karászi E; Fésüs L
    Biochem J; 1998 May; 331 ( Pt 3)(Pt 3):767-74. PubMed ID: 9560303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, structure-activity relationships, and RARgamma-ligand interactions of nitrogen heteroarotinoids.
    Dhar A; Liu S; Klucik J; Berlin KD; Madler MM; Lu S; Ivey RT; Zacheis D; Brown CW; Nelson EC; Birckbichler PJ; Benbrook DM
    J Med Chem; 1999 Sep; 42(18):3602-14. PubMed ID: 10479291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of retinoids on cancerous phenotype and apoptosis in organotypic cultures of ovarian carcinoma.
    Guruswamy S; Lightfoot S; Gold MA; Hassan R; Berlin KD; Ivey RT; Benbrook DM
    J Natl Cancer Inst; 2001 Apr; 93(7):516-25. PubMed ID: 11287445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of Calu-1 human lung carcinoma cell growth in serum-free medium by retinoids: dependence on AP-1 activation, but not on retinoid response element activation.
    Wan H; Dawson MI; Hong WK; Lotan R
    Oncogene; 1997 Oct; 15(17):2109-18. PubMed ID: 9366527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinoic acid receptor alpha expression correlates with retinoid-induced growth inhibition of human breast cancer cells regardless of estrogen receptor status.
    Fitzgerald P; Teng M; Chandraratna RA; Heyman RA; Allegretto EA
    Cancer Res; 1997 Jul; 57(13):2642-50. PubMed ID: 9205071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of retinoic acid receptor alpha is sufficient for full induction of retinoid responses in SK-BR-3 and T47D human breast cancer cells.
    Schneider SM; Offterdinger M; Huber H; Grunt TW
    Cancer Res; 2000 Oct; 60(19):5479-87. PubMed ID: 11034091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinobenzoic acids. 6. Retinoid antagonists with a heterocyclic ring.
    Eyrolles L; Kagechika H; Kawachi E; Fukasawa H; Iijima T; Matsushima Y; Hashimoto Y; Shudo K
    J Med Chem; 1994 May; 37(10):1508-17. PubMed ID: 8182710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of retinoid binding affinity to retinoic acid receptor alpha with retinoid inhibition of growth of estrogen receptor-positive MCF-7 mammary carcinoma cells.
    Dawson MI; Chao WR; Pine P; Jong L; Hobbs PD; Rudd CK; Quick TC; Niles RM; Zhang XK; Lombardo A
    Cancer Res; 1995 Oct; 55(19):4446-51. PubMed ID: 7671258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New isoxazole derivatives of retinoids: synthesis and activity on growth and differentiation of tumor cells.
    Simoni D; Manfredini S; Tabrizi MA; Bazzanini R; Baraldi PG; Ferroni R; Traniello F; Nastruzzi C; Feriotto G; Gambari R
    Drug Des Discov; 1992 Feb; 8(3):165-77. PubMed ID: 1525301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.